Skip to contentO
Opus Genetics, Inc.
O
IRDOpus Genetics, Inc. Q2 2015 · 10-Q
Revenue—
Net Income-$3.23M-$3.23MN/M vs Q2 2014 EPS Diluted-$0.02-$0.02— vs Q2 2014 Operating Income-$4,819,940N/M Operating Cash Flowderived-$4,402,901N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
ended Jun 30, 2015 · filed Aug 7, 2015 · 38 d after period end